JYNT Fundamental Analysis - JOINT CORP/THE

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to JYNT. JYNT was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for JYNT as it has an excellent financial health rating, but there are worries on the profitability. JYNT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year JYNT has reported negative net income.

In the past year JYNT had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: JYNT reported negative net income in multiple years.

Each year in the past 5 years JYNT had a positive operating cash flow.

1.2 Ratios

The Return On Assets of JYNT (-6.82%) is worse than 71.29% of its industry peers.

Looking at the Return On Equity, with a value of -21.48%, JYNT is doing worse than 65.35% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-6.82%
ROE	-21.48%
ROIC	N/A

ROA(3y)-7.05%

ROA(5y)1.52%

ROE(3y)-28.39%

ROE(5y)0.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 81.48%, JYNT belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.

JYNT's Gross Margin has declined in the last couple of years.

JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	81.48%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, JYNT has more shares outstanding

Compared to 5 years ago, JYNT has more shares outstanding

There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 3.26 indicates that JYNT is not in any danger for bankruptcy at the moment.

JYNT has a better Altman-Z score (3.26) than 68.32% of its industry peers.

JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	3.26

ROIC/WACCN/A

WACC8.88%

2.3 Liquidity

A Current Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.

JYNT's Current ratio of 1.80 is fine compared to the rest of the industry. JYNT outperforms 65.35% of its industry peers.

JYNT has a Quick Ratio of 1.80. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.

JYNT has a better Quick ratio (1.80) than 66.34% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.8
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.41%, which is quite impressive.

Looking at the last year, JYNT shows a decrease in Revenue. The Revenue has decreased by -9.68% in the last year.

JYNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.36% yearly.

EPS 1Y (TTM)72.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

Revenue 1Y (TTM)-9.68%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56.15%

3.2 Future

JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 73.24% yearly.

The Revenue is expected to decrease by -20.41% on average over the next years. This is quite bad

EPS Next Y97.68%

EPS Next 2Y91.85%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue Next Year-53.87%

Revenue Next 2Y-28.38%

Revenue Next 3Y-20.41%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.

JYNT is valuated quite expensively with a Price/Forward Earnings ratio of 28.70.

JYNT's Price/Forward Earnings ratio is in line with the industry average.

Compared to an average S&P500 Price/Forward Earnings ratio of 22.81, JYNT is valued a bit more expensive.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	28.7

4.2 Price Multiples

JYNT's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	48.14
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as JYNT's earnings are expected to grow with 73.24% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y91.85%

EPS Next 3Y73.24%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

JYNT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JOINT CORP/THE

NASDAQ:JYNT (8/22/2025, 8:19:53 PM)

After market: 10.61 0 (0%)

10.61

+0.15 (+1.43%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-07 2025-08-07/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners74.55%

Inst Owner Change5.03%

Ins Owners7.04%

Ins Owner Change7.19%

Market Cap162.76M

Analysts78.18

Price Target15.17 (42.98%)

Short Float %3.93%

Short Ratio9.01

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-1.93%

Min Revenue beat(2)-2.34%

Max Revenue beat(2)-1.53%

Revenue beat(4)1

Avg Revenue beat(4)-12.67%

Min Revenue beat(4)-51.14%

Max Revenue beat(4)4.33%

Revenue beat(8)3

Avg Revenue beat(8)-6.08%

Revenue beat(12)4

Avg Revenue beat(12)-4.64%

Revenue beat(16)6

Avg Revenue beat(16)-3.78%

PT rev (1m)-3.25%

PT rev (3m)-18.86%

EPS NQ rev (1m)-70%

EPS NQ rev (3m)-76%

EPS NY rev (1m)-115%

EPS NY rev (3m)-104.35%

Revenue NQ rev (1m)-2.35%

Revenue NQ rev (3m)-47.2%

Revenue NY rev (1m)-1.29%

Revenue NY rev (3m)-1.51%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	28.7
P/S	1.5
P/FCF	48.14
P/OCF	34.31
P/B	7
P/tB	7
EV/EBITDA	N/A

EPS(TTM)-0.24

EYN/A

EPS(NY)0.37

Fwd EY3.48%

FCF(TTM)0.22

FCFY2.08%

OCF(TTM)0.31

OCFY2.91%

SpS7.07

BVpS1.51

TBVpS1.51

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.82%
ROE	-21.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	81.48%
FCFM	3.12%

ROA(3y)-7.05%

ROA(5y)1.52%

ROE(3y)-28.39%

ROE(5y)0.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

F-Score6

Asset Turnover1.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	N/A
Cap/Depr	52.4%
Cap/Sales	1.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.8
Quick Ratio	1.8
Altman-Z	3.26

F-Score6

WACC8.88%

ROIC/WACCN/A

Cap/Depr(3y)57.36%

Cap/Depr(5y)93.23%

Cap/Sales(3y)6.25%

Cap/Sales(5y)6.57%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)72.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

EPS Next Y97.68%

EPS Next 2Y91.85%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue 1Y (TTM)-9.68%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56.15%

Revenue Next Year-53.87%

Revenue Next 2Y-28.38%

Revenue Next 3Y-20.41%

Revenue Next 5YN/A

EBIT growth 1Y-162.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year302.99%

EBIT Next 3Y74.18%

EBIT Next 5YN/A

FCF growth 1Y-70.37%

FCF growth 3Y6.31%

FCF growth 5Y15.29%

OCF growth 1Y-71.9%

OCF growth 3Y-12.05%

OCF growth 5Y4.6%

JOINT CORP/THE (JYNT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens